Racial differences in aldosterone excretion and plasma aldosterone concentrations in children

J H Pratt1, J J Jones, J Z Miller

  • 1Department of Medicine, Indiana University School of Medicine, Indianapolis 46202-5111.

Insights

Black children have significantly lower aldosterone secretion compared to white children, despite higher blood pressure. This difference in aldosterone levels, a hormone regulating blood pressure, is not fully explained by potassium intake.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiovascular Science

Background:

  • Hypertension is more prevalent in Black populations.
  • Black individuals often exhibit lower plasma renin activity and potassium intake than white individuals.
  • Secretion differences in aldosterone between racial groups are not well-established.

Purpose of the Study:

  • To investigate racial differences in aldosterone secretion between Black and White children.
  • To explore the relationship between aldosterone secretion, potassium intake, and blood pressure in children.

Main Methods:

  • Aldosterone and potassium excretion rates were measured in urine samples from 715 children (249 Black).
  • Dietary sodium and potassium intake were estimated via urinary excretion rates.
  • Plasma aldosterone levels were measured in a separate cohort of 99 children.

Main Results:

  • Black children exhibited significantly lower urinary aldosterone excretion rates compared to White children.
  • Lower potassium excretion rates were also observed in Black children.
  • Plasma aldosterone levels were substantially lower in Black children versus White children.
  • Higher systolic and diastolic blood pressures were noted in Black children.

Conclusions:

  • Black children secrete approximately 40% less aldosterone than White children.
  • Lower aldosterone secretion in Black children may contribute to higher blood pressure, but the exact mechanism remains unclear.
  • Dietary potassium intake partially explains, but does not fully account for, the observed differences in aldosterone secretion.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...